ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc.

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations by SpringWorks Therapeutics, Inc. related to its proposed acquisition by Merck KGaA, which is valued at approximately $3.4 billion [1]. Group 1 - The proposed acquisition will provide stockholders of SpringWorks Therapeutics with $47.00 for each share they hold [1]. - The transaction is expected to close in the second half of 2025 [1].